Late Relapse After Autologous Hematopoietic Stem Cell Transplantation in AQP4-IgG–Positive NMOSD
Vorasoot N., Blackburn KM., Nguyen L., Bush ML., Jenkins SM., Jitprapaikulsan J., Fryer JP., Irani SR., Flanagan EP., Pittock SJ.
This case series examines long-term outcomes for 2 aquaporin-4-IgG (AQP4-IgG)–positive patients with neuromyelitis optica spectrum disorder (NMOSD) who underwent autologous hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen and rituximab.